BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21623885)

  • 1. Drug-induced bullous pemphigoid: cases triggered by intravenous iodine and etanercept.
    Kluk J; Goulding JM; Bhat J; Finch TM
    Clin Exp Dermatol; 2011 Dec; 36(8):871-3. PubMed ID: 21623885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of coexisting bullous pemphigoid and psoriasis with the tumor necrosis factor antagonist etanercept.
    Yamauchi PS; Lowe NJ; Gindi V
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S121-2. PubMed ID: 16488323
    [No Abstract]   [Full Text] [Related]  

  • 3. A biological approach in a patient with psoriasis and bullous pemphigoid associated with losartan therapy.
    Saraceno R; Citarella L; Spallone G; Chimenti S
    Clin Exp Dermatol; 2008 Mar; 33(2):154-5. PubMed ID: 18021271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexisting bullous pemphigoid and psoriasis successfully treated with etanercept.
    Cusano F; Iannazzone SS; Riccio G; Piccirillo F
    Eur J Dermatol; 2010; 20(4):520. PubMed ID: 20403800
    [No Abstract]   [Full Text] [Related]  

  • 5. Subgroup analyses of etanercept in pediatric patients with psoriasis.
    Paller AS; Eichenfield LF; Langley RG; Leonardi CL; Siegfried EC; Creamer K; Kricorian G
    J Am Acad Dermatol; 2010 Aug; 63(2):e38-41. PubMed ID: 20633781
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bullous pemphigoid induced by photochemotherapy of psoriasis. Apropos of 2 cases, with a review of the literature].
    Brun P; Baran R
    Ann Dermatol Venereol; 1982; 109(5):461-8. PubMed ID: 6753695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple lentigines arising in resolving psoriatic plaques after treatment with etanercept.
    Costa LA; Belinchón I; Betlloch I; Pérez-Crespo M; Mataix J
    Dermatol Online J; 2008 Jan; 14(1):11. PubMed ID: 18319028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.
    Driessen RJ; Boezeman JB; van de Kerkhof PC; de Jong EM
    Br J Dermatol; 2009 Mar; 160(3):670-5. PubMed ID: 19210502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of psoriasis and psoriatic arthritis with etanercept: practical considerations on monotherapy, combination therapy, and safety.
    Yamauchi PS; Gindi V; Lowe NJ
    Dermatol Clin; 2004 Oct; 22(4):449-59, ix. PubMed ID: 15450340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent etanercept therapy in pediatric patients with psoriasis.
    Siegfried EC; Eichenfield LF; Paller AS; Pariser D; Creamer K; Kricorian G
    J Am Acad Dermatol; 2010 Nov; 63(5):769-74. PubMed ID: 20833444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lichen planopilaris noted during etanercept therapy in a child with severe psoriasis.
    Abbasi NR; Orlow SJ
    Pediatr Dermatol; 2009; 26(1):118. PubMed ID: 19250435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pemphigoid nodularis possibly induced by etanercept.
    Mochizuki M; Fujine E; Tawada C; Kanoh H; Seishima M
    J Dermatol; 2013 Jul; 40(7):578-9. PubMed ID: 23594393
    [No Abstract]   [Full Text] [Related]  

  • 13. Etanercept-induced lichenoid reaction pattern in psoriasis.
    Bovenschen HJ; Kop EN; Van De Kerkhof PC; Seyger MM
    J Dermatolog Treat; 2006; 17(6):381-3. PubMed ID: 17853314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-weekly administration of etanercept 50 mg improves patient-reported outcomes in patients with moderate-to-severe plaque psoriasis.
    Reich K; Segaert S; Van de Kerkhof P; Durian C; Boussuge MP; Paolozzi L; Wajdula J; Boggs R
    Dermatology; 2009; 219(3):239-49. PubMed ID: 19752505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etanercept in psoriasis treatment.
    Pietrzak A; Chodorowska G; Urban J; Roliński J; Pietrzak B
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):222-6. PubMed ID: 15314989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tinea versicolor associated with etanercept therapy.
    Levy MS; Polsky D; Davidson A; Strober BE
    J Am Acad Dermatol; 2008 May; 58(5 Suppl 1):S99-100. PubMed ID: 18489062
    [No Abstract]   [Full Text] [Related]  

  • 17. Etanercept combined with methotrexate for high-need psoriasis.
    Driessen RJ; van de Kerkhof PC; de Jong EM
    Br J Dermatol; 2008 Aug; 159(2):460-3. PubMed ID: 18547310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suspected rapid-onset neutropenia following etanercept use: disproved following rechallenge and lessons to be learned.
    Sachdev A; Shwayder T
    Int J Dermatol; 2013 Oct; 52(10):1287-8. PubMed ID: 22417135
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neutropenia and thrombocytopenia in a patient presenting psoriasis treated with etanercept].
    Lahbabi I; Adamski H; Le Jean S; Cannieux V; Polard E; Chevrant-Breton J
    Ann Dermatol Venereol; 2008 May; 135(5):409-10. PubMed ID: 18457732
    [No Abstract]   [Full Text] [Related]  

  • 20. Bullous pemphigoid during long-term TNF-alpha blocker therapy.
    Bordignon M; Belloni-Fortina A; Pigozzi B; Tarantello M; Alaibac M
    Dermatology; 2009; 219(4):357-8. PubMed ID: 19797890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.